Company intelligence / Profile preview

smallTalk

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

smallTalk is a developmental neuroscience company focused on optimizing infant brain development through early language exposure. The company's platform utilizes a specialized speaker device and curated audio content to introduce infants to the phonemes of multiple languages during their peak period of neuroplasticity. By leveraging research from Stanford and Columbia Universities, smallTalk aims to enhance cognitive flexibility and long-term learning outcomes. Their primary product is a nursery-based system that tracks and delivers linguistic stimuli tailored to the infant's developmental stage.

Therapeutic areas: Neurology
Modalities: DeviceDigital HealthNon-pharmacological therapy
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on smallTalk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on smallTalk.

Explore the full profile